Explore more publications!

Press Releases

Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
Israel Delays Gaza Medical Evacuations

Israel Delays Gaza Medical Evacuations

Israel Blocks Gaza Medical Evacuations Through Rafah Border

Israel Blocks Gaza Medical Evacuations Through Rafah Border

Israel Halts Evacuation of Gaza Patients, Their Departure Get Postponed

Israel Halts Evacuation of Gaza Patients, Their Departure Get Postponed

Israeli Fire Kills One Palestinian, Injures Another

Israeli Fire Kills One Palestinian, Injures Another

Israeli Strikes Kill at Least Sixteen People in Gaza

Israeli Strikes Kill at Least Sixteen People in Gaza

Israeli Strikes Kill Palestinians in Gaza

Israeli Strikes Kill Palestinians in Gaza

ANC Denounces S. Africa’s Leader for Inviting Israeli Officials

ANC Denounces S. Africa’s Leader for Inviting Israeli Officials

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
Catheter Precision Announces Accelerated Momentum for LockeT Device with New Hospital Approvals and Strong Q1 Adoption Outlook
UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ultragenyx Pharmaceutical Inc. – RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDT
Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions